Experimental Therapies for Relapsed Myeloma

 

Related Videos (117)

Dan Vogl, MD, discusses current clinical trials in drug therapy for relapsed and refractory myeloma, including carfilzomib, pomalidomide, ibrutinib, the monoclonal antibodies, the HDAC inhibitors and the oral proteosome inhibitors, and reviews the many clinical trials ongoing at Penn Medicine in the field.

 

Penn PhysicianLink®

Penn PhysicianLink® is an exclusive program that helps all referring physicians connect with Penn Medicine. This comprehensive package of support services expedites and facilitates direct physician communication for patient consults, referrals and transfers.

Learn more about Penn PhysicianLink®